- Open Access
γ-Tocotrienol does not substantially protect DS neurons from hydrogen peroxide-induced oxidative injury
© Then et al; licensee BioMed Central Ltd. 2012
- Received: 2 November 2011
- Accepted: 5 January 2012
- Published: 5 January 2012
Down syndrome (DS) neurons are more susceptible to oxidative stress and previous studies have shown that vitamin E was able to reduce oxidative stress and improve DS neurons' viability. Therefore, this study was done to investigate the protective role of γ-tocotrienol (γT3) in DS neurons from hydrogen peroxide (H2O2) -induced oxidative stress. The pro-apoptosis tendency of γT3 was compared to α-tocopherol (αT) in non-stress condition as well.
Primary culture of DS and euploid neurons were divided into six groups of treatment: control, H2O2, γT3 pre-treatment with H2O2, γT3 only, αT pre-treatment with H2O2 and αT only. The treatments were assessed by MTS assay and apoptosis assay by single-stranded DNA (ssDNA) apoptosis ELISA assay, Hoechst and Neu-N immunofluorescence staining. The cellular uptake of γT3 and αT was determined by HPLC while protein expressions were determined by Western blot. Comparison between groups was made by the Student's t test, one-way ANOVA and Bonferroni adjustment as well as two-way ANOVA for multiple comparisons.
One day incubation of γT3 was able to reduced apoptosis of DS neurons by 10%, however γT3 was cytotoxic at longer incubation period (14 days) and at concentrations ≥ 100 μM. Pre-treatment of αT and γT3 only attenuate apoptosis and increase cell viability in H2O2-treated DS and euploid neurons by 10% in which the effects were minimal to maintain most of the DS cells' morphology. γT3 act as a free radical scavenger by reducing ROS generated by H2O2. In untreated controls, DS neurons showed lower Bcl-2/Bax ratio and p53 expression compared to normal neurons, while cPKC and PKC-δ expressions were higher in DS neurons. On the other hand, pre-treatment of γT3 in H2O2-treated DS neurons have reduced Bcl-2/Bax ratio, which was not shown in euploid neurons. This suggests that pre-treatment of γT3 did not promote DS cell survival. Meanwhile γT3 and αT treatments without H2O2 as well as pre-treatment of γT3 and αT induced changes in cPKC and PKC-δ expression in DS neurons suggesting interaction of γT3 and αT with PKC activity.
Our study suggests that γT3 pre-treatment are not sufficient to protect DS neurons from H2O2-induced oxidative assault, instead induced the apoptosis process.
- Down syndrome
- human neurons
- oxidative stress
- vitamin E
Vitamin E is a generic term for lipid-soluble, chain breaking antioxidants which consists of four tocopherol isomers (α, β, γ, δ) and four tocotrienol isomers (α, β, γ, δ). The tocopherol and tocotrienol isomers differ in the number and position of methyl substitutions on the chromanol head. Although tocopherols and tocotrienols are closely related chemically, they differ in their biological effectiveness . Studies have shown that vitamin E deficiency impairs cognitive performance in mice subjected to oxidative stress . Meanwhile, one study found that Down syndrome (DS) children have significantly less vitamin E levels than normal children ; while another study showed that DS patients with dementia have lower plasma levels of vitamin E than controls without DS . These results suggest that intake of essential nutrients such as folate, vitamin B6, vitamin E, selenium, α-lipoic acid might be important in preventing cognitive deterioration in DS and Alzheimer disease (AD) .
However, intervention studies of antioxidant supplementation in DS and AD have not been conclusive. A recent randomized controlled trial on antioxidant supplementation, including vitamin E for DS children did not show any significant difference in developmental outcome after a two-year research period. There was also no significant effect of antioxidant supplementation on the superoxide dismutase and glutathione peroxidase activities, on the superoxide dismutase to glutathione peroxidase ratio and on the urinary isoprostane concentrations . Another recent review that looked at five different studies on antioxidants and cognitive functions revealed that only three studies examining vitamin E and C supplements gave significantly different results-i.e. one study found a positive association with specific cognitive test, while the other two studies showed a link with global cognitive functions . Other double-blind studies reported that vitamin E has no benefit in patients with mild cognitive impairment and Alzheimer's disease . In all these trials, subjects partake high doses of vitamin E (2000 IU or 1500 mg) daily, which is more than the upper tolerable intake level for vitamin E (1500 IU or 1000 mg per day) .
Vitamin E mainly function as free radical scavenger, but recent studies showed that tocopherols and tocotrienols have other non-antioxidant roles: α-tocopherol (αT) was shown to modulate signal transduction and gene expression in various cell lines, while tocotrienols possess powerful neuroprotective, anti-inflammatory anti-angiogenic, anti-artherogenic, anti-cancer and cholesterol lowering properties (for a comprehensive review, refer ). Vitamin E has been shown to be neuroprotective in various studies: firstly in a landmark study of neurodegeneration of in vitro culture of DS neurons ; followed by a study that reported that αT was able to attenuate oxidative stress-induced apoptosis in striatal neuron cultures via its free radical scavenger function ; while other studies showed that α-tocotrienol protects neurons from glutamate-induced cell death by the c-src activation molecular pathway . However, not many studies have address the possible pro-apoptotic tendency of vitamin E in neurons, especially tocotrienols, which has shown to have greater apoptotic activity towards various cancer cell lines such as mammary tumor cells and prostate tumor cells compared to tocopherols [14, 15]. Current studies has shown that tocopherol and vitamin E analogues were able to induced apoptosis in murine C6 glioma cell line and Tet21N neuroblastoma cell line [16, 17] but not tocotrienols.
γ-Tocotrienol (γT3) was reported to activate the apoptosis pathway via the mitochondrial death pathway of the Bcl-2 family proteins in pancreatic stellate cells , while tocotrienols was shown to be anti-proliferative in mammary epithelial cells by reducing PKCα (Protein Kinase C) activation . Our previous studies in primary rat's astrocytes and cerebellar neuron cultures revealed that high dosage of γT3 was cytotoxic and have a high tendency to induce the expressions of proteins that were involved in the apoptosis pathway such as Bax, p53 and p38 MAPK [20, 21]. Another study also showed that high doses of vitamin E and vitamin C enhanced the toxic effect of H2O2 to cells . Since most trials of vitamin E supplementations utilized high dosage of vitamin E for maximum effects, the concern for the safety of vitamin E supplementation at the molecular and cellular level has yet to be fully addressed. DS cells are known to be highly susceptible to oxidative damage compared to normal cells . Genomic and functional profiling of DS neural progenitor cell line exposed to S100B suggested that dysregulation of chromosome 21 genes led to increased ROS and thereby altered transcriptional regulation of cytoprotective genes in response to oxidative stress . Vitamin E treatment induced neuroinflammatory processes by increasing microglial activation in animals overexpressing S100B, which is involved in the neuropathology of DS and AD . Therefore, the purpose of this study is to further investigate the effects of αT and γT3 in the apoptosis signaling pathway of human DS neurons as a model of oxidative stress susceptible system, while normal human neurons were used as control.
The Malaysia Palm Oil Board (MPOB) supplied the palm γT3 and αT isomers of 87% and 80% purity respectively, which was isolated as described previously . Culture dishes were from Nunc while antibodies (p53, Bax, Bcl-2, cPKC, PKC-δ, β-actin) were from Santa Cruz Technologies. Reagents for 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays were from Promega while single-stranded DNA (ssDNA) Apoptosis ELISA kits were from Chemicon. All other chemicals and reagents were from Sigma unless indicated.
Primary cortical neuron cultures from normal and DS fetal brain
The cultures were established using human cortical brain tissues obtained from normal euploid and DS legally aborted fetuses at 14-21 weeks of gestation. The permission to use human fetal tissues was obtained from the ethics committee of the Spanish National Research Council (CSIC) (Approval date: August 6th, 2009; ref. no: SAF2009-13093-C02-02). Enriched neuron cultures were prepared as described elsewhere .
Cell culture treatments
Neuron cultures were incubated with varying concentrations of γT3 and αT, with αT as a positive control based on previous studies showing αT having non-toxic and neuroprotective effects on neurons [12, 21]. Stock solutions of 0.5 M γT3 and αT (in 100% ethanol) were first resolved overnight in fetal calf serum at 37°C and diluted to 100 times the final concentration with culture media containing 50% ethanol. Final dilution of αT and γT3 in the cell culture contained 0.5% ethanol, which did not significantly affect cell survival (data not shown). All experiments utilized freshly prepared dilutions of H2O2, αT and γT3.
Cytotoxicity of γT3
The human DS neuron cultures were incubated with γT3 (1-200 μM) for 24 hours at 37°C. DS neurons were also given γT3 treatment of 7 days and 14 days to determine possible cytotoxicity or protective effects of γT3. Cytotoxicity of γT3 and αT was assessed by propidium iodide (PI) assay. Briefly, for PI assay, the cultures in 96 wells were stained with PI (7 μM) for one hour prior to the end of the incubation period (24 h. 7 days and 14 days). At the end of the incubation period, the fluorescence intensity was determined and expressed relative to cultures treated with 0.2% Triton X-100 (to permeabilize all cells). The fluorescence signal was measured by a fluorescence plate reader (Molecular Devices, USA) at 530-nm excitation ⁄ 645-nm emission to quantify cell membrane damage as described elsewhere .
Detection of Cell Survival
DS and euploid cortical neurons were pre-treated with varying concentrations of αT and γT3 (1-100 μM) for one hour at 37°C, followed by addition of H2O2 (100 μM) to the cells and a further incubation for 24 hours at 37°C before cell viability and apoptosis were assessed. Cell viability was assessed using MTT assay. Briefly, the cell culture media was loaded with 0.5 mg/mL MTT to detect any decrease in the cell metabolic activity using MTT reduction assay following standard procedures . Meanwhile, the rate of apoptosis was measured using the ssDNA ELISA kit as described previously . In addition, cell viability was also assessed utilizing the PI assay as described above. For cell imaging, DS neuron cultures were stained with of Neu-N (neuron- specific nuclear protein) antibody to confirm the results shown by the MTT and ssDNA ELISA assay. Briefly, cells were fixed with 4% paraformaldehyde before being permeabilized with 0.25% Triton in PBS for 30 mins. The cells were then washed with PBS, followed by incubation with goat serum at room temperature to block unspecific binding site, and incubation with mouse Neu-N antibody (Chemicon, USA) in 1:200 dilution overnight at 4°C. Subsequently, cultures were washed with PBS and incubated with anti-mouse Alexa Fluor 488 (Molecular Probes, The Netherlands) in 1:2000 dilution for 1 hr at room temperature. After washing with PBS, nuclei were counterstained with Hoescht before visualization under fluorescence microscope (Nikon, Japan) at 40× magnification. The intracellular production of ROS was determined using DCFH-DA assay. Non-fluorescent DCFH-DA was permeable to cell membrane and oxidation of hydroperoxides produced fluorescent 2',7'-dichlorofluorescein (DCF), which was detected by fluorescence plate reader at 485 nm excitation/530 nm emission .
Determination of Vitamin E Uptake by HPLC
The uptake of γT3 and αT was analyzed using reverse-phase high performance liquid chromatography (HPLC) Fluorescent EM 330 nm, EX 294 nm detector (Shimadzu, Japan) as described previously . Concentration peaks of the samples were compared with tocotrienol rich fraction (TRF) standard and the concentrations of αT and γT3 uptake in cells were calculated as μM/106 cells.
SDS-PAGE and Western Blot
Western blot of DS and euploid (normal) cortical neurons in various treatment groups were used to elucidate the expression of proteins involved in the apoptosis signaling pathway including p53, Bax, Bcl-2, cPKC (for detection of common isoforms PKC-α, PKC-β and PKC-γ) and PKC-δ; while β-actin were used as housekeeping protein and loading control. A maximum protective dosage of 10 μM γT3 and αT was used to test if this concentration could induce apoptosis in DS and euploid neurons. The western blots were performed as previously described.
Each experiment of cultures in microplates was carried out in triplicate wells with at least three independent cultures. The data were reported as mean ± SD of at least three experiments. Comparison between groups was made by the Student's t test, one-way ANOVA and Bonferroni adjustment as well as two-way ANOVA for multiple comparisons. p < 0.05 was considered as statistically significant for Student t-test whereas p < 0.0001 was considered as statistically significant for multi-factor comparisons.
Aberrant expression of PKC signalling has been reported in fetal DS post-mortem tissues , while DS patients' fibroblast was reported to be hyposensitive to PKC . However, both studies did not specify the location of PKC isoforms involvement. From previous study, cPKC was shown to be activated when exposed to oxidative stress in neuronal death induced by ischemia, hypoxia and exitotoxicity , whereas other studies revealed that an increase in PKC-δ expression was needed for glutamate-induced neuronal death , Parkinson's disease model  and AGE-induced neuronal death  as well as H2O2-induced oxidative stress . Across the various treatment groups, the expression of cPKC was higher in DS neurons compared to euploid neurons. However, the cPKC expression of DS neurons was down-regulated in all other treatment groups (γT3 followed by H2O2, γT3, αT followed by H2O2, and αT), as shown in Figure 5 (a) (iv) and Figure 6 (c). From Figure 5 (a) (v) and Figure 6 (d), DS neurons showed a 2-fold increase of PKC-δ expression in H2O2-treated neurons, suggesting an accumulation of PKC-δ in the cytosol, which signified pro-apoptotic activities in neurons  were suppressed by the pre-treatment of γT3, while the pre-treatment of αT did not alter PKC-δ expression. In normal euploid neurons, H2O2 induced increased cPKC expression [Figure 5 (b) (iv) and Figure 6 (c)] but suppressed PKC-δ [Figure 5 (b) (v) and Figure 6 (d)]. Pre-treatment of γT3 suppressed the cPKC expression but elevated the PKC-δ expression; while the pre-treatment of αT was found to increase the cPKC expression but down-regulated PKC-δ expression [Figure 6 (c) and Figure 6 (d)]. αT has been known to inhibit PKC-α activities [47, 48] which was not shown in euploid neurons pre-treated with αT in Figure 5 (b) (iv) and Figure 6 (c). Meanwhile a high concentration of αT (500 μM) has been shown to inhibit PKC-δ activation in AGE-induced neuronal death  in which lower dose of αT pretreatment in euploid neurons showed similar result [Figure 5 (b) (v) and Figure 6 (d)]. However, the incubation of only γT3 also showed a decrease in cPKC, similar to a previous study which showed that γT3 suppressed PKC-α expression . This suggests that besides functioning as an antioxidant, γT3 might also play a role in modulating PKC-δ expression as PKC-δ is a redox sensitive molecule.
This study revealed that in DS neurons, even though γT3 pre-treatment provided initial slight improvement in neuron viability, the protection from both αT and γT3 pre-treatment was not substantial to protect DS neurons from H2O2 assault. Furthermore, pre-treatment of γT3 would reduce the Bcl-2/Bax ratio that indicates cell survival while αT pre-treatment did not suppress pro-apoptotic PKC-δ expression in the cells. However, in non-oxidative stress condition, αT and γT3 did not exert strong pro-apoptosis tendency in human DS and euploid neurons compared to our previous studies in rat neurons . DS neurons has been shown to have chronic overexpression of S100B, in which oxidation of S100B preferentially induced the neurotrophic processes (which is beneficial for cell survival and differentiation) over neuroinflammation processes. However treatment with antioxidants such as vitamin E interrupts this feedback and leads to increase glial activation and cell death . This may explain the reason why in DS neurons, αT and γT3 at the concentrations used in this study may aggravate cellular damages in a highly susceptible neuronal cell model subjected to oxidative stress. Our present results further underlie the importance of more study to be done on the safety of vitamin E supplementation in neurodegenerative diseases such as DS and AD. Although γT3 act as a free radical scavenger which could quench ROS generated from H2O2, it may also synergistically induce apoptosis and autophagy through the mitochondrial death pathway, including the Bcl-2 family proteins . Meanwhile, our study also showed that αT has a different mechanism of action compared to γT3, which remains to be further elucidated.
We are grateful to Dr Santiago Barambio, Yolanda Trejo and Raquel Lopez from Tutor Medica Clinics, Barcelona, and Dr Nuria Toran from Hospital de la Vall d'Hebron, Barcelona, for their assistance in providing the tissue samples for this work. This study was funded by the Ministry of Science, Technology and Innovation Malaysia under the Intensified Research Prioritized Area (IRPA) grant 06-02-02-002/PR0008/09-07, SAF2009-13093-C02-02 from MICINN and RD06/0013/1004 from ISCIII, Spain.
- Yoshida Y, Niki E, Noguchi N: Comparative study on the action of tocopherols and tocotrienols as antioxidants: chemical and physical effects. Chem Phys Lipids. 2003, 123: 63-75. 10.1016/S0009-3084(02)00164-0.View ArticleGoogle Scholar
- Mihalick SM, Ortiz D, Kumar R, Rogers E, Shea TB: Folate and vitamin E deficiency impair cognitive performance in mice subjected to oxidative stress: differential impact on normal mice and mice lacking apolipoprotein E. Neuromolecular Med. 2003, 4: 197-201. 10.1385/NMM:4:3:197.View ArticleGoogle Scholar
- Cengiz M, Seven M: Vitamin and mineral status in Down syndrome. Trace Elem Electrolytes. 2000, 17: 156-160.Google Scholar
- Jackson CV, Holland AJ, Williams CA, Dickerson JW: Vitamin E and Alzheimer's disease in subjects with Down's syndrome. J Ment Defic Res. 1999, 32: 479-484.Google Scholar
- Theil R, Fowkes SW: Can cognitive deterioration associated with Down syndrome be reduced? Med. Hypotheses. 2005, 64: 524-532. 10.1016/j.mehy.2004.08.020.View ArticleGoogle Scholar
- Ellis JM, Tan HK, Gilbert RE, Muller DPR, Henley W, Moy R, Pumphrey R, Ani C, Davies S, Edwards V, Green H, Salt A, Logan S: Supplementation with antioxidants and folinic acid for children with Down's syndrome: randomized controlled trial. BMJ. 2008, 336: 594-597. 10.1136/bmj.39465.544028.AE.View ArticleGoogle Scholar
- Ancelin ML, Christen Y, Ritchie K: Is antioxidant therapy a viable alternative for mild cognitive impairment? Examination of the evidence. Dement Geriatr Cogn Disord. 2007, 24: 1-19. 10.1159/000102567.View ArticleGoogle Scholar
- Isaac MG, Quinn R, Tabet N: Vitamin E for Alzheimer's disease and mild cognitive impairment. Cochrane Database Syst Rev.Google Scholar
- Arab L, Barr SI, Becking GC, Beecher GR, Borra ST, Burk RF, Carriquiry AL, Chan AC, Devaney BL, Dwyer JT, Erdman JJW, Habicht J-P, Jacob RA, Jialal I, Kimbrough RD, Kolonel LN, Krinsky NI, Kuhnlein HV, Marshall JR, Mayne ST, Messing RB, Miller SA, Munro IC, Murphy SP, Pastides H, Prentice RL, Rodricks JV, Rosenberg IH, Schwarz KB, Steinberg D, al e: Dietary Reference Intakes: Vitamin C, Vitamin E, Selenium and Carotenoids. 2000, Washington, D. C., Institute of MedicineGoogle Scholar
- Sen CK, Khanna S, Roy S: Tocotrienols: Vitamin E beyond tocopherols. Life Sci. 2006, 78: 2088-2098. 10.1016/j.lfs.2005.12.001.View ArticleGoogle Scholar
- Busciglio J, Yankner B: Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro. Nature. 1995, 378: 776-779. 10.1038/378776a0.View ArticleGoogle Scholar
- Osakada F, Hashino A, Kume T, Katsuki H, Kaneko S, Akaike A: Neuroprotective effects of alpha-tocopherol on oxidative stress in rat straital cultures. Eur J Pharmacol. 2003, 465: 15-22. 10.1016/S0014-2999(03)01495-X.View ArticleGoogle Scholar
- Sen C, Khanna S, Roy S, Packer L: Molecular basis of vitamin E action: tocotrienol potently inhibits glutamate-induced pp60cSrc kinase activation and death of HT4 neuronal cells J. Biol Chem. 2000, 275: 13049-13055. 10.1074/jbc.275.17.13049.View ArticleGoogle Scholar
- Wali VB, Sylvester PW: Synergistic antiproliferative effects of gamma-tocotrienol and statin treatment on mammary tumor cells. Lipids. 2007, 42: 1113-1123. 10.1007/s11745-007-3102-0.View ArticleGoogle Scholar
- Kumar KS, Raghavan M, Hieber K, Ege C, Mog S, Parra N, Hildabrand A, Singh V, Srinivasan V, Toles R, Karikari P, Petrovics G, Seed T, Srivastava S, Papas A: Prefencial radiation sensitization of prostate cancer in nude mice by nutraceutical antioxidant c-tocotrienol. Life Sci. 2006, 78: 2099-2104. 10.1016/j.lfs.2005.12.005.View ArticleGoogle Scholar
- Betti M, Minelli A, Canonico B, Castaldo P, Magi S, Aisa MC, Piroddi M, Di Tomaso V, Galli F: Antiproliferative effects of tocopherols (vitamin E) on murine glioma C6 cells: homologue-specific control of PKC/ERK and cyclin signaling. Free Radic Biol Med. 2006, 41: 464-472. 10.1016/j.freeradbiomed.2006.04.012.View ArticleGoogle Scholar
- Gogvadze V, Norberg E, Orrenius S, Zhivotovsky B: Involvment of Ca2+ and ROS in alpha-tocopheryl succinate-iduced mitochondrial permeabilization. Int J Cancer. 2010, 127: 1823-1832. 10.1002/ijc.25204.View ArticleGoogle Scholar
- Rickmann M, Vaquero EC, Malagelada JR, Molero X: Tocotrienols induce apoptosis and autophagy in rat pancreatic stellate cells through the mitochondrial death pathway. Gastroenterol. 2007, 132: 2518-2532. 10.1053/j.gastro.2007.03.107.View ArticleGoogle Scholar
- Sylvester PW, McIntyre BS, Gapor A, Briski KP: Vitamin E inhibition of normal mammary epithelial cell growth is associated with a reduction in protein kinase Calpha activation. Cell Prolif. 2001, 34: 347-357. 10.1046/j.1365-2184.2001.00221.x.View ArticleGoogle Scholar
- Mazlan M, Sue Mian T, Mat Top G, Zurinah Wan NW: Comparative effects of alpha-tocopherol and gamma-tocotrienol against hydrogen peroxide induced apoptosis on primary-cultured astrocytes. J Neurol Science. 2006, 243: 5-12. 10.1016/j.jns.2005.10.006.View ArticleGoogle Scholar
- Then SM, Mazlan M, Gapor MT, Wan Ngah WZ: Is vitamin E toxic to neurons?. Cell Mol Neurobiol. 2009, 29: 485-496. 10.1007/s10571-008-9340-8.View ArticleGoogle Scholar
- Shang F, Lu M, Dudek E, Reddan J, Taylor A: Vitamin C and vitamin E restore the resistance of GSH-depleted lens cells to H2O2. Free Radic Biol Med. 2003, 34: 521-530. 10.1016/S0891-5849(02)01304-7.View ArticleGoogle Scholar
- Zana M, Janka Z, Kalman J: Oxidative stress: a bridge between Down's syndrome and Alzheimer's disease. Neurobiol Aging. 2007, 28: 648-676. 10.1016/j.neurobiolaging.2006.03.008.View ArticleGoogle Scholar
- Esposito G, Imitola J, Lu J, Filippis D, Scuderi C, Ganesh VS, Folkerth R, Hecht J, Shin SJ, Luvone T, Chesnut J, Steardo L, Sheen V: Genomic and functional profiling of human Down syndrome neural progenitors implicates S100B and aquaporin 4 in cell injury. Human Mol Gen. 2008, 17: 440-457.View ArticleGoogle Scholar
- Bialowas-McGoey LA, Lesicka A, Whitaker-Azmitia PM: Vitamin E increases S100B-mediated microGLIA activation in an S100B-overexpressing mouse model of pathological aging. Glia. 2008, 56: 1780-1790. 10.1002/glia.20727.View ArticleGoogle Scholar
- Choo YM, Ma AN, Basiron Y: A method of chromotagraphic isolation for vitamin E isomers. 2001, European Patent EP1122250; United States Patent 6656358Google Scholar
- Sebastia J, Cristofol R, Pertusa M, Vilchez D, Toran N, Barambio S, Rodriguez-Farre E, Sanfeliu C: Down's syndrome astrocytes have greater antioxidant capacity than euploid astrocytes. Eur J Neurosci. 2004, 20: 2355-2366. 10.1111/j.1460-9568.2004.03686.x.View ArticleGoogle Scholar
- Rosa R, Sanfeliu C, Suñol C, Pomés A, Rodríguez-Farré E, Schousboe A, Frandsen A: The mechanism for hexachlorocyclohexane-induced cytotoxicity and changes in intracellular Ca2+ homeostasis in cultured cerebellar granule cell neurons is different for the c and d isomers. Toxicol Appl Pharmacol. 1997, 142: 31-39. 10.1006/taap.1996.7968.View ArticleGoogle Scholar
- Hansen MB, Nielsen SE, Berg K: Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods. 1989, 119: 203-210. 10.1016/0022-1759(89)90397-9.View ArticleGoogle Scholar
- Sebastia J, Cristofol R, Martin M, Rodriguez-Farre E, Sanfeliu C: Evaluation of fluorescent dyes for measuring intracellular glutathione content in primary cultures of human neurons and neuroblastoma SH-SY5Y. Cytometry Part A. 2003, 51: 16-25.View ArticleGoogle Scholar
- Reboul E, Trompier D, Moussa M, Klein A, Landrier J, Chimini G, Borel P: ATP-binding cassette transporter A1 is significantly involved in the intestinal absorption of alpha- and gamma-tocopherol but not in that of retinyl palmitate in mice. Am J Clin Nutr. 2009, 89: 177-184.View ArticleGoogle Scholar
- Oram J, Vaugham A, Stocker R: ATP-binding cassette transporter A1 mediates cellular secretion of alpha-tocopherol. J Biol Chem. 2001, 276: 39898-39902. 10.1074/jbc.M106984200.View ArticleGoogle Scholar
- Mullen RJ, Buck CR, Smith AM: NeuN, a neuronal specific nuclear protein in vertabrates. Development. 1992, 116: 201-211.Google Scholar
- Zhang H, Kong X, Kang J, Su J, Zhong J, Sun L: Oxidative stress induces parallel autophagy and mitochondria dysfunction in human glioma U251 cells. Toxicol Sci. 2009, 110: 376-388. 10.1093/toxsci/kfp101.View ArticleGoogle Scholar
- Majumder P, Mishra N, Sun X, Bharti A, Kharbanda S, Saxena S, Kufe D: Targeting of protein kinase C delta to mitochondria in the oxidative stress response. Cell Growth Differ. 2001, 12: 465-470.Google Scholar
- Yamaguchi T, Miki Y, Yoshida K: Protein kinase C δ activates IκB-kinase α to induce the p53 tumor suppressor in response to oxidative stress. Cell Signalling. 2007, 19: 2088-2097. 10.1016/j.cellsig.2007.06.002.View ArticleGoogle Scholar
- Helguera P, Pelsman A, Pigino G, Wolvetang E, Head E, Busciglio J: est-2 promotes the activation of a mitochondrial death pathway in Down's syndrome neurons. Neurobiol Dis. 2005, 25: 2295-2303.Google Scholar
- Engidawork E, Balic N, Juranville JF, Fountoulakis M, Dierssen M, G L: Unaltered expression of Fas (CD95/APO-1), caspase-3, Bcl-2 and annexins in brains of fetal Down syndrome: evidence against increased apoptosis. J Neural Transm Suppl. 2001, 61: 149-162.Google Scholar
- Numakawa Y, Numakawa T, Matsumoto T, Yagasaki Y, Kumamaru E, Kunugi H, Taguchi T, Niki E: Vitamin E protected cultured cortical neurons from oxidative stress-induced cell death through activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase. J Neurochem. 2006, 97: 1191-1202. 10.1111/j.1471-4159.2006.03827.x.View ArticleGoogle Scholar
- Peyrl A, Weitzdoerfer R, Gulesserian T, Fountoulakis M, Lubec G: Aberrant expression of signaling-related proteins 14-3-3 gamma and RACK1 in fetal Down syndrome brain (trisomy 21). Electrophoresis. 2002, 23: 152-157. 10.1002/1522-2683(200201)23:1<152::AID-ELPS152>3.0.CO;2-T.View ArticleGoogle Scholar
- Govoni S, Bergamaschi S, Gasparini L, Quaglia C, Racchi M, Cattaneo E, Binetti G, Bianchetti A, Giovetti F, Battaini F, Trabuechi M: Fibroblasts of patients affected by Down's syndrome oversecrete amyloid precursor protein and are hyporesponsive to protein kinase C stimulation. Neurology. 1996, 47: 1069-1075.View ArticleGoogle Scholar
- Durkin JP, Tremblay R, Chakravarthy B, Mealing G, Morley P, Small D, Song D: Evidence that the early loss of membrane protein kinase C is a necessary step in the excitatory amino acid-induced death of primary cortical neurons. J Neurochem. 1997, 68: 1400-1412.View ArticleGoogle Scholar
- Choi B, Hur E, Lee J, Jun D, Kim K: Protein kinase C delta-mediated proteasomal degradation of MAP kinase phosphatase-1 contributes to glutamate-induced neuronal cell death. J Cell Sci. 2006, 119: 1329-1340. 10.1242/jcs.02837.View ArticleGoogle Scholar
- Kanthasamy AG, Anantharam V, Zhang D, Latchoumycandane C, Jin H, Kaul S, Kanthasamy A: A novel peptide inhibitor targeted to caspase-3 cleavage site of a proapoptotic kinase protein kinase C delta (PKCδ) protects against dopaminergic neuronal degeneration in Parkinson's disease models. Free Radic Biol & Med. 2006, 41: 1578-1589. 10.1016/j.freeradbiomed.2006.08.016.View ArticleGoogle Scholar
- Nitti M, d'Abramo C, Traverso N, Verzola D, Garibotto G, Poggi A, Odetti P, Cottalasso D, Marinari UM, Maria A, Pronzato MA, Domenicotti C: Central role of PKC-delta in glycoxidation-dependent apoptosis of human neurons. Free Radic Biol Med. 2005, 38: 846-856. 10.1016/j.freeradbiomed.2004.12.002.View ArticleGoogle Scholar
- Carvour M, Song C, Kaul S, Anantharam V, Kanthasamy A, Kanthasamy A: Chronic low-dose oxidative stress induces caspase-3-dependent PKCdelta proteolytic activation and apoptosis in a cell culture model of dopaminergic neurodegeneration. Ann N Y Acad Sci. 2008, 1139: 197-205. 10.1196/annals.1432.020.View ArticleGoogle Scholar
- Ricciarelli R, Tasinato A, Clement S, Ozer NK, Boscoboinik D, Azzi A: alpha-Tocopherol specifically inactivates cellular protein kinase C a by changing its phosphorylation state. Biochem J. 1998, 334: 243-249.View ArticleGoogle Scholar
- Carter CA, Kane CJ: Therapeutic potential of natural compounds that regulate the activity of protein kinase C. Curr Med Chem. 2004, 11: 2883-2902.View ArticleGoogle Scholar
- Yap WN, Chang PN, Han HY, Lee DTW, Ling MT, Wong YC, Yap YL: gamma-tocotrienol suppresses prostate cancer cell proliferation and invasion through multiple signalling pathways. Brit J Cancer. 2008, 99: 1832-1841. 10.1038/sj.bjc.6604763.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.